Government And Institutions

APNewsBreak: Feds: NY was overpaid for health exchange setup

New York improperly used as much as $150 million in grants to set up its insurance exchange under President Barack Obama's health care law and help people enroll for coverage, according to a federal audit released Tuesday.

APNewsBreak: Feds: NY was overpaid for health exchange setup

New York improperly used as much as $150 million in grants to set up its insurance exchange under President Barack Obama's health care law and help people enroll for coverage, according to a federal audit released Tuesday.

What's On Our Radar: November 22, 2016

Here's what's On Our Radar today: No more coal for Canada, Amazon is turning to sports and Trump sheds light on his first 100 days in office.

What's On Our Radar: November 22, 2016

Here's what's On Our Radar today: No more coal for Canada, Amazon is turning to sports and Trump sheds light on his first 100 days in office.

Defectors: N. Korea would fall without capitalistic markets

Hundreds of capitalistic markets, each with thousands of stalls, form the glue that holds North Korea's socialist planned economy together, say defectors who sold medicinal herbs, skinny jeans, TV sets, foreign drama CDs and other goods there to make a living.

Defectors: N. Korea would fall without capitalistic markets

Hundreds of capitalistic markets, each with thousands of stalls, form the glue that holds North Korea's socialist planned economy together, say defectors who sold medicinal herbs, skinny jeans, TV sets, foreign drama CDs and other goods there to make a living.

EpiPen manufacturer will be a no-show at Senate hearing

Senate Judiciary Chairman Charles Grassley says pharmaceutical company Mylan is declining to testify at his committee's hearing next week on a settlement between the company and the Justice Department over its life-saving Epi-Pen.

EpiPen manufacturer will be a no-show at Senate hearing

Senate Judiciary Chairman Charles Grassley says pharmaceutical company Mylan is declining to testify at his committee's hearing next week on a settlement between the company and the Justice Department over its life-saving Epi-Pen.